Advertisement

Topics

22nd Century Reports on New Responses to the FDA’s Nicotine Reduction Plan

09:35 EDT 11 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Scientists highlight reduced consumption; refute claims of compensation; support an immediate reduction in nicotine level 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tob...

Other Sources for this Article

22nd Century Group
James Vail, 716-270-1523
Director of Communications
jvail@xxiicentury.com

NEXT ARTICLE

More From BioPortfolio on "22nd Century Reports on New Responses to the FDA’s Nicotine Reduction Plan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...